CNTG Centogene NV: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Centogene NV - graphic logo of issuer CNTG

This EV/EBITDA price chart for Centogene N.V. (CNTG) on the GURU.Markets platform captures the metric at . Centogene N.V. (CNTG) has established a comprehensive ecosystem for identifying rare pathologies by integrating diagnostics with analytics for the pharmaceutical industry. Leadership is driven by a massive genome archive and the application of neural networks. Meanwhile, molecular tests are conducted in-house, while data array storage is outsourced to reliable cloud providers.

Centogene N.V. - CNTG Total Company Value to Operating Income Before Depreciation Ratio (period 07/04/2022 - 11/10/2026)

Summary analytical data breakdowns for CENTOGENE N.V. (CNTG)

- stock price and consensus target price:
Stock Quotes centogene.com|CNTG - Average Forecast Price
- company stock capitalization data:
Market Value Centogene|CNTG - Company Buyout Price
- book value of equity indicators:
Book Value per Share CENTOGENE|CNTG - Book Valuation of Business|Market Value to Book Value Ratio centogene.com|CNTG - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Capital Centogene N.V.|CNTG - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Centogene NV|CNTG - Company Cumulative Debt|Debt to Book Capitalization Ratio Centogene|CNTG - Company Long-Term Indebtedness|Company Current Liabilities CENTOGENE|Quick Liquidity centogene.com
- financial results and valuation multiples details:
CNTG - Company Net Income|Projected Future Earnings Centogene N.V.|CNTG - Market Cap to Net Income Ratio|Forward P/E Multiple Centogene N.V.|CNTG - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Centogene|CNTG - Operating profit before amortization|Net earnings per share (EPS TTM) CENTOGENE|CNTG - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months centogene.com|CNTG - Earnings per share increase in current year|Net earnings per share growth forecast for next year Centogene N.V.
Initial company analysis:CNTG (Centogene)
Product sample of CENTOGENE N.V.

This multiple compares the total enterprise value, including net debt, with operating profit before depreciation and amortization, determining the payback period for all assets. By analyzing the EV/EBITDA ratio of a company across a financial timeline, an investor identifies business overvaluation or hidden risks of model degradation. For Centogene N.V. (CNTG), such a metric is critical, as stable demand for genetics offsets market volatility, highlighting the resilience of this defensive medical asset.

Competitor analysis for Centogene N.V.

Agilent Tech - Enterprise Value to EBITDA Ratio|Quest Corp (DGX) - Company Value to EBITDA|ILMN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|RVTY: EV/EBITDA Multiple|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anbio Tech|Nordion (SHC) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple QDEL|Enterprise Value to EBITDA Ratio opko.com OPK|EV/EBITDA Multiple CDNA (CareDx Inc)|Maravai LifeSciences Holdings (MRVI) - Company Value to EBITDA|FLGT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LAB (Standard BioTools Corp) - Enterprise Value to Operating Income Before Depreciation|CTKB (Cytek Biosciences, Inc.) - Enterprise Value to EBITDA Ratio|OSUR: Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Exagen Inc|Company Value to EBITDA MDxHealth S.A. MDXH|EV/EBITDA Multiple LUCD|prenetics.com (PRE) - Enterprise Value to EBITDA Multiple|EV/EBITDA Multiple IMDX (Insight Molecular Diagnostics Inc)|Trinity Biotech PLC (TRIB) - Company Value to EBITDA|PRPH - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AIMD (Ainos Inc) - Enterprise Value to Operating Income Before Depreciation|CODX: EV/EBITDA Multiple|Company Value to EBITDA Heart Test Labs (HSCS)|Enterprise Value to EBITDA Ratio BMRA|CDIO: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Onconetix (ONCO)|Virax Biolabs Group Limited - Enterprise Value to Operating Income Before Depreciation|Bluejay - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Aspira Women's Health Inc (AWH)|AXDX: Enterprise Value to EBITDA Ratio|ENZ: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|FRES (fresh2.co) - Enterprise Value to EBITDA Ratio|GENE - Total Company Value to Operating Income Before Depreciation Ratio|ME (23andMe Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Psychemedics Inc (PMD)